arrow
F

Fabrizio Bossa

Fondazione IRCCS Casa Sollievo della Sofferenza
H指数:39
被引数:5,769

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Parente et al. Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience. Diagnostics 2022, 12, 685

修正:Parente等人. 接受ICI治疗并出现胃肠道毒性的患者的临床、内镜和组织学特征:来自单一机构经验的最新消息和重新评估。Diagnostics 2022, 12, 685

2026-07-290
OA
Rare AFG3L2 and POLG Variants Suggest a Role for Mitochondrial Dysfunction in Enteric Neuronal Vulnerability in Idiopathic Achalasia

罕见AFG3L2和POLG变异提示线粒体功能障碍在特发性贲门失弛缓症肠道神经元易感性中的作用

2026-07-290
OAAI
Pattern-based histologic approach in colitis without chronic architectural damage: GIPAD recommendations

基于模式的炎症性肠病组织学评估方法(无慢性结构损伤):GIPAD建议

2026-05-020
OAAI
Machine learning approach and internet of things technologies to unravel the complex interaction between microbiome-metabolome in inflammatory bowel disease: a new frontier in precision medicine

机器学习方法和物联网技术揭示炎症性肠病中微生物组-代谢组之间的复杂相互作用: 精准医学的新前沿

2025-12-100
OAAI
When to Switch to Subcutaneous Infliximab? The RE-WATCH Multicenter Study

Bertani, L.; Ribaldone, D.G.; Bossa, F.; Guerra, M.; Annese, M.; Manta, R.; Armandi, A.; Caviglia, G.P.; Todeschini, A.; Variola, A. 何时切换至皮下注射英夫利昔单抗?RE-WATCH多中心研究。Inflamm. Bowel Dis. 2025, 31, 3363–3369. [Google Scholar] [CrossRef]

2025-09-013
PRE
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)

托法替尼治疗溃疡性结肠炎相关脊柱关节病的真实世界有效性:一项来自意大利炎症性肠病研究小组(IG-IBD)的多中心前瞻性研究

2025-08-250
OA
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy (RETUCAS): a Multicentre Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)
2025-01-220
PRE
Real-world efficacy and safety of Upadacitinib in IBD patients. Preliminary data from the Apulian Network for Inflammatory Bowel Disease (AN-IBD)
2025-01-220
PRE
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies - Insights from the IUS IG-IBD (Italian Group for the Study of Inflammatory Bowel Disease) Master Program
2025-01-220
PRE
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)
2024-09-012
PRE
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence

炎症性肠病基因组学、转录组学、蛋白质组学和宏基因组学符合人工智能

2024-08-316
OAAI
Deciphering Microbial Composition in Patients with Inflammatory Bowel Disease: Implications for Therapeutic Response to Biologic Agents

破译炎症性肠病患者的微生物组成: 对生物制剂治疗反应的影响

2024-06-214
OAAI
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study
2024-01-010
OAAI
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study
2024-01-0111
OAAI